Skip to main content

Advertisement

Table 1 Demographic data and baseline characteristics: Phase I

From: Early versus delayed administration of norepinephrine in patients with septic shock

Characteristic 28-day survivors (n = 133) 28-day non-survivors (n = 80) Pvalue
Age (years) 58.2 ± 11.9 59.5 ± 14.4 0.507
Gender, number (%)    0.684
Male 71 (53.4) 45 (56.2)  
Female 62 (46.6) 35 (43.8)  
Weight (kg) 64.0 ± 13.8 64.7 ± 13.2 0.708
Serum lactate at septic shock onset (mmol/L) 4.3 ± 1.4 5.3 ± 1.5 <0.001
APACHE II score 27.2 ± 3.9 30.4 ± 3.9 <0.001
Documented infection, number (%) 117 (88.0) 74 (92.5) 0.293
Culture positive, number (%) 108 (81.2) 67 (83.8) 0.638
Primary infection site, number (%)    0.675
Respiratory 23 (17.3) 18 (22.5)  
Intra-abdominal 46 (34.6) 28 (35.0)  
Genitourinary 13 (9.8) 5 (6.3)  
Skin and soft tissue 5 (3.8) 2 (2.5)  
Intravascular catheter 15 (11.3) 10 (12.5)  
Bloodstream 8 (6.0) 8 (10.0)  
Other 23 (17.3) 9 (11.3)